In this video interview, Marc Buyse, ScD, founder and CEO of IDDI, examines the most common threats to trial data reliability, including opaque methodologies, synthetic controls, and the limits of ...

A web-based tool that incorporates patient preference in antidepressant selection was associated with a significant decrease ...

Particle therapy experts gathered in London to discuss the transformative potential of laser-driven proton and ion beams ...

Thomas Smith Leerink Partners LLC, Research Division. Good morning, everyone. Thanks for joining us here at the Leerink Partners Global Healthcare Conference. My name is Tom Smith ...

Barclays 28th Annual Global Healthcare Conference March 10, 2026 11:30 AM EDTCompany ParticipantsRyan Cohlhepp - ...

Achieved randomization target of 230 patients in LEVEL study, topline data expected in third quarter of 2026 Initiated global Phase 3 LEVEL-2 clinical trial and opened long-term OLE study for patients ...

Osteoarthritis is usually framed as the price of just getting older. Many people imagine a knee that slowly wears down, then never recovers. That picture is familiar, yet it is too simple.

Call of Duty officially reveals the full patch notes for Black Ops 7 and Warzone's big Season 2 Reloaded update, which goes ...

Artificial intelligence is transforming food innovation by accelerating ingredient discovery, optimizing formulations, and enabling personalized nutrition strategies to improve public health outcomes.

Achieved randomization target of 230 patients in LEVEL study, topline data expected in third quarter of 2026Initiated global Phase 3 LEVEL-2 ...

To our knowledge, this analysis is the largest EHR-based study for identifying drug repurposing candidates for ALS. We identified several drugs that warrant further assessment as therapeutic options ...

Background Gut bacteria have been implicated in a wide range of health conditions, yet their potential role in preventing and treating muscle-wasting disorders remains largely unexplored. Objective We ...